These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11270970)

  • 21. Comparative in vitro activity of fleroxacin (RO 23-6240) against Ureaplasma urealyticum and Mycoplasma hominis.
    Krausse R; Ullmann U
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):67-9. PubMed ID: 3132382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H; Bébéar C
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species.
    Rennie KA; Prasad ES; Wenman WM
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):57-9. PubMed ID: 7867300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the Mycoplasma Plus and the SIR Mycoplasma kits for quantitative detection and antibiotic susceptibility testing of genital mycoplasma].
    Renaudin H; Bebear C
    Pathol Biol (Paris); 1990 May; 38(5):431-5. PubMed ID: 2195452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1515-6. PubMed ID: 1929320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro comparison of the activity of various antibiotics and drugs against new Taiwan isolates and standard strains of avian mycoplasma.
    Lin MY
    Avian Dis; 1987; 31(4):705-12. PubMed ID: 3442523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].
    Bebear C; Cantet P; Renaudin H; Quentin C
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):577-80. PubMed ID: 3937130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of erythromycin, tetracycline and levofloxacin alone and in dual combinations against ureaplasma spp.
    Luo DQ; Liu JY; Yang W; Zhang B; Yu MJ; Wu YM
    Chemotherapy; 2011; 57(2):128-33. PubMed ID: 21430380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
    Yancey RJ; Klein LK
    J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of Mycoplasma hyosynoviae and M. hyorhinis to antimicrobial agents.
    Kobayashi H; Sonmez N; Morozumi T; Mitani K; Ito N; Shiono H; Yamamoto K
    J Vet Med Sci; 1996 Nov; 58(11):1107-11. PubMed ID: 8959659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
    Rumpianesi F; Morandotti G; Sperning R; Satta G; Cevenini R
    J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens.
    Ye G; Jiang Z; Wang M; Huang J; Jin G; Lu S
    Cell Biochem Biophys; 2014 Jan; 68(1):207-10. PubMed ID: 23749559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibilities of field isolates of Mycoplasma agalactiae.
    Antunes NT; Tavío MM; Assunção P; Rosales RS; Poveda C; de la Fé C; Gil MC; Poveda JB
    Vet J; 2008 Sep; 177(3):436-8. PubMed ID: 17604191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
    García-Castillo M; Morosini MI; Gálvez M; Baquero F; del Campo R; Meseguer MA
    J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility and susceptibility testing of Mycoplasma hominis: a review.
    Bygdeman SM; Mårdh PA
    Sex Transm Dis; 1983; 10(4 Suppl):366-70. PubMed ID: 6364407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro antibiotic sensitivity of French strains of Mycoplasma bovis].
    Poumarat F; Martel JL
    Ann Rech Vet; 1989; 20(2):145-52. PubMed ID: 2751228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Male urogenital tract mycoplasma infection and drug-resistance evolution].
    Guo X; Ye Z; Deng R
    Zhonghua Nan Ke Xue; 2004 Feb; 10(2):122-4. PubMed ID: 15027187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further characterization of the in vitro and in vivo activity of ciprofloxacin against mycoplasmas.
    Furneri PM; Tempera G; Chiarenza A; Caccamo F; Speciale AM; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):346-9. PubMed ID: 3123079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.